Similar to humans, animals too suffer from chronic diseases. Arthritis and other orthopedic conditions, chronic kidney disease, cancer, hepatitis and other liver diseases, skin allergies, diabetes mellitus, inflammatory bowel disease, and thyroid disorders are among the common chronic diseases in pets.

1. Companion Animal Diagnostics Market
Companion Animal Diagnostics Market
Forecast to 2027 - Covid-19 Impact and
Global Analysis by Technology
(Immunodiagnostics, Clinical Biochemistry,
Hematology, Urinalysis, Molecular
Diagnostics, and Others); Application
(Bacteriology, Clinical Pathology, Virology,
Parasitology, and Others); Animal Type
(Dogs, Cats, Horses, and Others); End User
(Diagnostic Laboratories, Veterinary
Hospitals and Clinics, Research Institutes
and Universities);and Geography

2. Current and future Market Scenario
 According to The Insight Partners market research study titled “Companion Animal Diagnostics Market”
 to 2027 - Global Analysis and Forecasts by Type, by Application, the companion animal diagnostics market was valued at
US$ 2,031.62 million in2019 and is projected to reach US$ 2,684.86 million by 2027.
 The report highlights the trends prevalent in the Companion Animal Diagnostics Market and the factors driving the
market along with those that act as deterrents to its growth.
The Companion Animal Diagnostics Market on the basis of Technology is segmented into Immunodiagnostics, Clinical
Biochemistry, Hematology, Urinalysis, Molecular Diagnostics, and Others. In 2019, the Companion Animal Diagnostics
Market segment accounted for the largest market share in the global Companion Animal Diagnostics Market by type.
 Companion Animal Diagnostics Market is expected to grow at a CAGR of 4.1%from 2020to 2027.The companion animal
diagnostics market offerings deal with the epidemiology and pathogenesis of domestic animals and facilitate the
prevention of further complications with the health of pets and their owners.
Companion Animal Diagnostics Market

3. Key Findings
 The companion animal diagnostics market is expected to witness huge growth due to growing prevalence of chronic
diseases in pet animals and increasing adoption of pets for companionship.
 However, increasing pet care costs and extended pet lifespan are expected to restrain the growth of the market during
the forecast period.
Market Insights
Growing Prevalence of Chronic Diseases in Pet Animals
Similar to humans, animals too suffer from chronic diseases. Arthritis and other orthopedic conditions, chronic kidney
disease, cancer, hepatitis and other liver diseases, skin allergies, diabetes mellitus, inflammatory bowel disease, and
thyroid disorders are among the common chronic diseases in pets. As per the veterinary cancer society, cancer is a
leading cause of death in 47% of dogs, especially in dogs of age >10 years, and 32% of cats.

4. Market Segments
Companion Animal Diagnostics Market
By Technology
(Immunodiagnostics,
Clinical Biochemistry,
Hematology, Urinalysis,
Molecular Diagnostics, and
Others
)
By Application
(Bacteriology, Clinical
Pathology, Virology,
Parasitology, and Others)
End User (Diagnostic
Laboratories, Veterinary
Hospitals and Clinics,
Research Institutes and
Universities)

5. Dominating Segments
 Cancer is widespread in animals and affects pet as well as wild animals. Animals have been diagnosed with
various types of cancer till date, which have symptoms similar to humans, including weight loss, abnormal
swelling, and lethargy.
 FETCH a Cure, a nonprofit organization, has estimated that over 6 million dogs and ~6 million cats would be
diagnosed with cancer in 2020. Furthermore, as per the Pet Cancer Facts and Figures, one in four dogs and
one in five cats develop cancer in their lifetime
 According to the association for pet obesity prevention (APOP), in 2018, ~55.8% of dogs and 59.5% of cats in
the US were overweight or obese..
Companion Animal Diagnostics Market

6. Product Insights
Type Insights
 Based on technology, the companion animal diagnostics market is further segmented into immunodiagnostics,
clinical biochemistry, hematology, urinalysis, molecular diagnostics, and others. The immunodiagnostics segment
is further sub-segmented into lateral flow assays, Elisa tests, allergen-specific immunodiagnostic tests, and
immunoassay analyzers. Whereas the clinical biochemistry segment is sub-segmented into clinical chemistry
analysis, glucose monitoring, and blood gas electrolyte analysis.
 The immunodiagnostics segment held a largest share of the market in 2019 owing to the increasing adoption of
immunodiagnostic assays such as lateral flow assays, ELISA tests, allergen-specific immunodiagnostic tests, and
immunoassay analyzers in the diagnosis of a wide range of disease in pets.
 Download PDF Brochure https://www.theinsightpartners.com/sample/TIPRE00004558/?source=Others-10381
Dominating Segments

7. The report segments the global Companion Animal Diagnostics Market as follows:
Global Companion Animal Diagnostics Market- By Technology
Immunodiagnostics
Clinical Biochemistry
Hematology
Urinalysis
Molecular Diagnosticsand Others
Global Companion Animal Diagnostics Market- By Application
Bacteriology
Clinical Pathology
Virology
Parasitology and Others
Dominating Segments

8. Global Companion Animal Diagnostics Market- By End User
Diagnostic Laboratories
Veterinary Hospitals
Clinics
Research Institutes
Universities
Global Coronary Stents Market - Animal Type
Dogs
Cats
Horses and Others
Dominating Segments

9. Leading Players
Hemophilia Treatment Market
Company Profiles in Companion Animal Diagnostics Market are:
Zoetis Inc.
Thermo Fisher Scientific Inc.
Virbac
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Randox Laboratories, Ltd.
Idvet
IDEXX Laboratories, Inc.
Heska Corporation
Fujifilm Corporation
Skyla Corporation

10. REGIONAL FRAMEWORK
REGIONAL FRAMEWORK

11. Companion Animal Diagnostics Market

12. Thank You!
Companion Animal DiagnosisMarket
Access Full Research Report at:
https://www.theinsightpartners.com/sample/TIPRE00004558/?source=Others-10381
Thank You!